Clinical Trial Update: Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating celecoxib as add-on to risperidone versus risperidone alone in schizophrenia. The study has completed and reports efficacy and safety f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Celecoxib (Celecoxib)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Pfizer | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED